Found 28 matching trials
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents PHASE2 The purpose of the study was to evaluate the immunogenicity and describe th...
Show More Location
Multiple Locations
Treatments Being Tested
Meningococcal Polysaccharide (Serogroups A, C, Y, and W135) Tetanus Toxoid Conjugate Vaccine Meningococcal (Groups A, C, Y and W135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine Adacel®: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed GARDASIL®: Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant Meningococcal Polysaccharide (Serogroups A, C, Y, and W135) Tetanus Toxoid Conjugate Vaccine Adacel®: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed GARDASIL®: Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant Learn More & Join Trial
Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or With Two Other Vaccines in Healthy Adolescents PHASE3 Primary Objective:
To demonstrate the non-inferiority of the seroprotectio...
Show More Location
Investigational Site Number :3480003
Learn More & Join Trial
A Study to Assess the Safety of Adacel® Vaccine PHASE3 The objective of this study is to describe the safety of Adacel® vaccinatio...
Show More Location
Multiple Locations
Learn More & Join Trial
Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine PHASE4 Objectives:
To provide safety data on revaccination with ADACEL® vaccine.
...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents PHASE4 The aim of this study is to describe immunogenicity of a single booster dos...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America PHASE2 The purpose of this study is to generate immunogenicity and safety data in ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older PHASE4 It is well recognized that older adults can contract pertussis, suffer its ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents PHASE1 This study is designed to assess the immunogenicity and safety of tetanus t...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Immunogenicity Study for Use of Menactra® Versus Adacel® in Subjects 11 to 55 Years of Age in South Korea PHASE3 The aim of the study is to assess safety and immunogenicity of a single dos...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine PHASE4 The purpose of this study was to evaluate the immunogenicity and safety of ...
Show More Location
Multiple Locations
Learn More & Join Trial